Panel discussion featured at the International Society of Pain and Neuroscience (ISPN) Annual Meeting in London titled United to Conquer Pain Session Co-Moderator Doug Beall, M.D. underscored that ...

In a recent study published in Biomaterials, researchers developed a novel non-viral gene therapy for discogenic back pain (DBP) by delivering a developmental-type transcription factor, Forkhead Box ...

PHOENIX, Arizona — Patients treated with radiofrequency intradiscal biacuplasty (IDB) for discogenic low back pain show maintenance of improvements in pain and physical function for as long as a year ...

Recognition Follows 2025 HLTH Digital Health Award for Nociscan. Award Winning AI Targets a Large and Costly Chronic Low Back Pain Market . BROOMFIELD, Colo., April 14, 2026 (GLOB ...

FDA has previously agreed on the design of this 300-patient randomized, placebo-controlled confirmatory Phase 3 trial, and the 12-month primary endpoint of pain reduction as an approvable indication.

(HealthDay News) — High-quality studies evaluating nonoperative treatments for reducing discogenic low back pain are lacking, according to a review published in the July 15 issue of Spine. Young Lu, ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Results showed a high-dose injection of allogeneic disc progenitor cells for treatment of degenerative ...

MELVILLE, N.Y., Feb. 27, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical ...

Failed back surgical syndrome is a broad diagnosis describing a patient who has symptoms of pain following some type of spinal surgery. This might be confusing and may seem to imply that the surgery ...